Bioaccessibility of lead and arsenic in traditional Indian medicines

Science of the Total Environment

Volumn 409, Issue 21, 2011, Pages 4545-4552

  Koch, Iris ^a   Moriarty, Maeve ^a   House, Kim ^a   Sui, Jie ^a   Cullen, William R ^b   Saper, Robert B ^c   Reimer, Kenneth J ^a  

^a ROYAL MILITARY COLLEGE OF CANADA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Ayurvedic; Bioaccessibility; Lead; Risk; Speciation

Indexed keywords

ACCEPTABLE DAILY INTAKES; ARSENIC CONCENTRATION; ARSENIC SPECIATION; AYURVEDIC; AYURVEDIC MEDICINE; BIOACCESSIBILITY; GASTROINTESTINAL TRACT; LEAD BIOACCESSIBILITY; SPECIATION; TOXIC ELEMENTS; X-RAY ABSORPTION NEAR-EDGE STRUCTURE;

ARSENIC; CALCINATION; ORGANIC ACIDS;

LEAD COMPOUNDS;

AMOEBICA; AROGYAVARDHINI BATI; ARSENIC; BAKUCHI; BRAHMI; CARBOXYLIC ACID; CHAIRATA; EZI SLIM; JATAMANSI; KANCHANAR GUGGULU; KANTA KARI; LAVAN BHASKAR; LEAD; LEAN PLUS; MAHASUDARSHAN; MAHAYOGRAJ GUGGULU; NATURAL PRODUCT; NEEM PLUS; PANCREATIN; PEPSIN A; PRANA; PRAVAL PISTI; SHILAJEET; SODIUM CHLORIDE; TRIFALA GUGGULU; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAL LADY; WORRY FREE; YOG RAJ GUGGULU; YOGARAJ GUGGULU;

ARSENIC; CONCENTRATION (COMPOSITION); LEAD; MEDICINE; SOLUBILITY; SPECIATION (CHEMISTRY);

ARTICLE; AYURVEDA; BACOPA MONNIERI; BIOACCUMULATION; COMMIPHORA; DRUG CAPSULE; DRUG EXPOSURE; DRUG SOLUBILITY; GLYCYRRHIZA; PH; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TABLET FORMULATION; TRADITIONAL MEDICINE; X RAY ABSORPTION SPECTROSCOPY;

ANIMALS; ARSENIC; ARSENICALS; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN-ION CONCENTRATION; INDIA; LEAD; MATERIA MEDICA; MEDICINE, AYURVEDIC; MEDICINE, TRADITIONAL; PLANT EXTRACTS; RISK ASSESSMENT; SPECTROMETRY, X-RAY EMISSION;

EID: 80052519888     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2011.07.059     Document Type: Article

References (48)

1. Aldrich M.V., Peralta-Videa J.R., Parsons J.G., Gardea-Torresdey J.L. Examination of arsenic(III) and (V) uptake by the desert plant species mesquite (Prosopis spp.) using X-ray absorption spectroscopy. Sci Total Environ 2007, 379:249-255.
2. Amiard J.C., Amiard-Triquet C., Charbonnier L., Mesnil A., Rainbow P.S., Wang W.X. Bioaccessibility of essential and non-essential metals in commercial shellfish from Western Europe and Asia. Food Chem Toxicol 2008, 46:2010-2022.
3. Andrahennadi R., Fu J.X., Pushie M.J., Wiramanaden C.I.E., George G.N., Pickering I.J. Insect excretes unusual six-coordinate pentavalent arsenic species. Environ Chem 2009, 6:298-304.
4. Basta N.T., Foster J.N., Dayton E.A., Rodriguez R.R., Casteel S.W. The effect of dosing vehicle on arsenic bioaccessibility in smelter-contaminated soils. J Environ Sci Health Part A-Tox/Haz Sub Environ Eng 2007, 42:1275-1281.
5. Bluemlein K., Raab A., Feldmann J. Stability of arsenic peptides in plant extracts: off-line versus on-line parallel elemental and molecular mass spectrometric detection for liquid chromatographic separation. Anal Bioanal Chem 2009, 393:357-366.
6. Centers for Disease Control and Prevention Lead poisoning associated with use of Ayurvedic medications - five states, 2000-2003. MMWR Morb Mortal Wkly Rep 2004, 53:582-584.
7. Deshpande A.A., Rhodes C.T., Shah N.H., Malick A.W. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm 1996, 22:531-539.
8. Ernst E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol 2002, 57:891-896.
9. Franke F.W., Moxon A.L. A comparsion of the minimun fatal doses of selenium, tellurium, arsenic and vanadium. J Pharmacol Exp Ther 1936, 58:454-459.
10. Health Canada Contaminated Sites Division Safe Environments Programme Federal contaminated site risk assessment in Canada: Part II: Health Canada Toxicological References Values (TRVs) and chemical-specific factors 2009, Government of Canada, Ottawa, ON.
11. Jayawardene I., Saper R., Lupoli N., Sehgal A., Wright R.O., Amarasiriwardena C. Determination of in vitro bioaccessibility of Pb, As, Cd and Hg in selected traditional Indian medicines. J Anal At Spectrom 2010, 25:1275-1282.
12. Joint FAO/WHO Expert Committee on Food Additives Summary report of the seventy-second meeting of JECFA 2010, 1-16. FAO/WHO, Geneva, Switzerland.
13. Joint FAO/WHO Expert Committee on Food Additives Summary report of the seventy-third meeting of JECFA 2010, 1-17. FAO/WHO, Geneva, Switzerland.
14. Juhasz A.L., Weber J., Smith E., Naidu R., Rees M., Rofe A., et al. Assessment of four commonly employed in vitro arsenic bioaccessibility assays for predicting in vivo relative arsenic bioavailability in contaminated soils. Environ Sci Technol 2009, 43:9487-9494.
15. Koch I., Steven S., Lai V.W.M., Owen A., Reimer K.J., Cullen W.R. Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills. Toxicol Appl Pharmacol 2007, 222:357-364.
16. Koch I., Wang L.X., Ollson C.A., Cullen W.R., Reimer K.J. The predominance of inorganic arsenic species in plants from Yellowknife, Northwest Territories, Canada. Environ Sci Technol 2000, 34:22-26.
17. Kong F., Singh R.P. A model stomach system to investigate disintegration kinetics of solid foods during gastric digestion. J Food Sci 2008, 73:E202-E210.
18. Kumar A., Nair A.G.C., Reddy A.V.R., Garg A.N. Unique ayurvedic metallic-herbal preparations, chemical characterization. Biol Trace Elem Res 2006, 109:231-254.
19. Laparra J.M., Velez D., Montoro R., Barbera R., Farre R. Bioaccessibility of inorganic arsenic species in raw and cooked Hizikia fusiforme seaweed. Appl Organomet Chem 2004, 18:662-669.
20. Liu J., Lu Y.F., Wu Q., Goyer R.A., Waalkes M.P. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite. J Pharmacol Exp Ther 2008, 326:363-368.
21. Meunier L., Walker S.R., Wragg J., Parsons M.B., Koch I., Jamieson H.E., et al. Effects of soil composition and mineralogy on the bioaccessibility of arsenic from tailings and soil in gold mine districts of Nova Scotia. Environ Sci Technol 2010, 44:2667-2674.
22. Meunier L., Wragg J., Koch I., Reimer K.J. Method variables affecting the bioaccessibility of arsenic in soil. J Environ Sci Health Part A-Tox/Haz Sub Environ Eng 2010, 45:517-526.
23. Mir K.A., Rutter A., Koch I., Smith P., Reimer K.J., Poland J.S. Extraction and speciation of arsenic in plants grown on arsenic contaminated soils. Talanta 2007, 72:1507-1518.
24. Park J.D., Liu Y.P., Klaassen C.D. Protective effect of metallothionein against the toxicity of cadmium and other metals. Toxicology 2001, 163:93-100.
25. Pickering I.J., Prince R.C., George M.J., Smith R.D., George G.N., Salt D.E. Reduction and coordination of arsenic in Indian mustard. Plant Physiol 2000, 122:1171-1177.
26. Ravel B., Newville M. Athena, Artemis, Hephaestus: data analysis for X-ray absorption spectroscopy using ifeffit. J Synchrotron Radiat 2005, 12:537-541.
27. Raza Z.B. Clinical trial in rheumatoid and osteoarthritis of an indigenous drug combination. Patna J Med 1975, 49:70-73.
28. Richardson G.M., Bright D.A., Dodd M. Do current standards of practice in Canada measure what is relevant to human exposure at contaminated sites? II: oral bioaccessibility of contaminants in soil. Hum Ecol Risk Assess 2006, 12:606-616.
29. Rochette E.A., Bostick B.C., Li G.C., Fendorf S. Kinetics of arsenate reduction by dissolved sulfide. Environ Sci Technol 2000, 34:4714-4720.
30. Rodriguez R.R., Basta N.T., Casteel S.W., Pace L.W. An in vitro gastrointestinal method to estimate bioavailable arsenic in contaminated soils and solid media. Environ Sci Technol 1999, 33:642-649.
31. Ruby M.V., Davis A., Link T.E., Schoof R., Chaney R.L., Freeman G.B., et al. Development of an in-vitro screening-test to evaluate the in-vivo bioaccessibility of ingested mine-waste lead. Environ Sci Technol 1993, 27:2870-2877.
32. Ruby M.V., Davis A., Schoof R., Eberle S., Sellstone C.M. Estimation of lead and arsenic bioavailability using a physiologically based extraction test. Environ Sci Technol 1996, 30:422-430.
33. Saper R.B., Kales S.N., Paquin J., Burns M.J., Eisenberg D.M., Davis R.B., et al. Heavy metal content of Ayurvedic herbal medicine products. Jama-J Am Med Assoc 2004, 292:2868-2873.
34. Saper R.B., Phillips R.S., Sehgal A., Khouri N., Davis R.B., Paquin J., et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. Jama-J Am Med Assoc 2008, 300:915-923.
35. Satpute A.D. Rasa Ratna Samuchaya of Vagbhatta, trans. Varanasi, India. Chaukhamba Sanskrit Pratishthan, Delhi 2003.
36. Scarr M., Maltby J.R., Jani K., Sutherland L.R. Volume and acidity of residual gastric fluid after oral fluid ingestion before elective ambulatory surgery. Can Med Assoc J 1989, 141:1151-1154.
37. Schroder J.L., Basta N.T., Casteel S.W., Evans T.J., Payton M.E., Si J. Validation of the in vitro gastrointestinal (IVG) method to estimate relative bioavailable lead in contaminated soils. J Environ Qual 2004, 33:513-521.
38. Shastri K. Rasa Tarangini of Sadananda Sharma, trans 1979, Motilal Banarsidass, New Delhi, India.
39. Simha K.R.G., Laxminarayana V., Prasad S.V.L.N., Khanum S. Standardisation of Yogaraja guggulu - an Ayurvedic polyherbal formulation. Indian J Tradit Knowl 2008, 7:389-396.
40. Singh V., Garg A.N. Availability of essential trace elements in Ayurvedic Indian medicinal herbs using instrumental neutron activation analysis. Appl Radiat Isot 1997, 48:97-101.
41. Smith P.G., Koch I., Gordon R.A., Mandoli D.F., Chapman B.D., Reimer K.J. X-ray absorption near-edge structure analysis of arsenic species for application to biological environmental samples. Environ Sci Technol 2005, 39:248-254.
42. Smith P.G., Koch I., Reimer K.J. Uptake, transport and transformation of arsenate in radishes (Raphanus sativus). Sci Total Environ 2008, 390:188-197.
43. Stark S.C., Snape I., Graham N.J., Brennan J.C., Gore D.B. Assessment of metal contamination using X-ray fluorescence spectrometry and the toxicity characteristic reaching procedure (TCLP) during remediation of a waste disposal site in Antarctica. J Environ Monit 2008, 10:60-70.
44. Thatte U.M., Rege N.N., Phatak S.D., Dahanukar S.A. The flip side of Ayurveda. J Postgrad Med 1993, 39:179-182.
45. U.S.EPA Office of Solid Waste and Emergency Response. Estimation of relative bioavailability of lead in soil and soil-like materials using in vivo and in vitro methods 2007, U.S. EPA.
46. United States Environmental Protection Agency (USEPA) Method 6200: field portable X-ray fluorescence spectrometry for the determination of elemental concentrations in soil and sediment 2007, USEPA, Washington, DC, SW-846.
47. Van de Wiele T.R., Oomen A.G., Wragg J., Cave M., Minekus M., Hack A., et al. Comparison of five in vitro digestion models to in vivo experimental results: lead bioaccessibility in the human gastrointestinal tract. J Environ Sci Health Part A-Tox/Haz Sub Environ Eng 2007, 42:1203-1211.
48. Younis I.R., Stamatakis M.K., Callery P.S., Meyer-Stout P.J. Influence of pH on the dissolution of folic acid supplements. Int J Pharm 2009, 367:97-102.